When biomarkers for major depressive disorder remain elusive

Medical Review · Published 2024-12-23 · DOI 10.1515/mr-2024-0082

Authors being retrieved — see the publisher record. https://doi.org/10.1515/mr-2024-0082

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Gaseous biomarkers speak medical conditions · Medical Review · 2026 · Same journal
• Unfolding ecDNA as a pan-cancer therapeutic target · Medical Review · 2025 · Same journal
• The AI doctor will see you soon: from assistants to autonomous practitioners · Medical Review · 2025 · Same journal
• Target discovery-directed pharmacological mechanism elucidation of bioactive natural products · Medical Review · 2025 · Same journal
• Severe trauma care: advances and future directions in diagnostic and therapeutic techniques and information technology support · Medical Review · 2026 · Same journal
• Artificial intelligence-based software as a medical device: regulatory evolution toward continuous oversight · Medical Review · 2026 · Same journal
• Proactive personalized early warning systems: the next frontier in climate–health preparedness · Medical Review · 2026 · Same journal
• Transfer RNA-derived small RNAs (tsRNAs) in Alzheimer’s disease: emerging mechanisms and diagnostic potential · Medical Review · 2026 · Same journal
• Obesity: current developments in mechanisms, diagnosis, classification and the evolution of personalized management · Medical Review · 2026 · Same journal
• Transcript diversity in aging: cryptic transcription and splicing · Medical Review · 2025 · Same journal